Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) Overcomes Oxaliplatin Resistance and Promotes Anti-Tumor Immunity in Colorectal Cancer.
Cancer Research - United States
doi 10.1158/0008-5472.can-18-2807
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2019
Authors
Publisher
American Association for Cancer Research (AACR)